SCHEMBL9350089

SCHEMBL9350089

CC(=O)c1ccc(C(C)C(=O)Cl)cc1C(C)=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 9/20 0.36
AKR1C2 P52895 9/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PTGS2 P35354 4/20 0.33
PTGS1 P23219 3/20 0.33
ALDH1A1 P00352 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CDC42 P60953 1/20 0.33
RAC1 P63000 1/20 0.33
CYP1A2 P05177 1/20 0.33
TSHR P16473 1/20 0.33
SLC22A6 Q4U2R8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9345918 0.83 AKR1C3 (0.51) AKR1C3AKR1C2SMN1; SMN2PTGS2PTGS1
SCHEMBL30744065 0.79 UGT2B7 (0.44) AKR1C3AKR1C2SMN1; SMN2TDP1ALDH1A1
SCHEMBL29279726 0.79 UGT2B7 (0.44) AKR1C3AKR1C2SMN1; SMN2TDP1ALDH1A1
SCHEMBL9257901 0.77 PTGS2 (0.46) AKR1C3AKR1C2PTGS2PTGS1CYP2C9
SCHEMBL13144265 0.74 ALDH1A1 (0.47) SMN1; SMN2TDP1ALDH1A1MEN1KMT2A
SCHEMBL10980506 0.74 PTGS1 (0.47) SMN1; SMN2TDP1PTGS2PTGS1ALDH1A1
SCHEMBL23276955 0.73 TDP1 (0.48) TDP1PTGS2PTGS1ALDH1A1MEN1
SCHEMBL8559116 0.73 ALDH1A1 (0.51) AKR1C3AKR1C2SMN1; SMN2PTGS1ALDH1A1
SCHEMBL3141629 0.73 ALDH1A1 (0.51) AKR1C3AKR1C2SMN1; SMN2PTGS2PTGS1
SCHEMBL27581017 0.73 ALDH1A1 (0.51) AKR1C3AKR1C2SMN1; SMN2PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0333522-B1 Catechol derivatives and pharmaceutical preparations containing same MITSUI TOATSU CHEMICALS (JP) 1994-08-17 EP disclosed
US-5232923-A Stimulates production of nerve growth factor; administering for treatment of regressive disorders of the central nervous system MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1993-08-03 US disclosed